Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0Q2DE
|
|||
Former ID |
DNC012208
|
|||
Drug Name |
CHOLINE IODIDE
|
|||
Synonyms |
Choline iodide; 17773-10-3; 2-Hydroxy-N,N,N-trimethylethanaminium iodide; Jodoetano; Dilatol zambon; UNII-39528O55VK; EINECS 241-754-2; (2-Hydroxyethyl)trimethylammonium Iodide; AI3-61505; CHEMBL293410; Ethanaminium, 2-hydroxy-N,N,N-trimethyl-, iodide; 39528O55VK; CholineIodide; AC1L3DCR; AC1Q1TNR; ACMC-209ed9; SCHEMBL315876; CTK4D6569; ANW-22891; MFCD00011900; AKOS027320917; 2-hydroxyethyl(trimethyl)azanium iodide; ACM17773103; KS-0000140P; LS-53247; KB-76072; TC-111636; FT-0623771; C-45721; Ethanaminium,2-hydroxy-N,N,N-trimethyl-, io
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C5H14INO
|
|||
Canonical SMILES |
C[N+](C)(C)CCO.[I-]
|
|||
InChI |
1S/C5H14NO.HI/c1-6(2,3)4-5-7;/h7H,4-5H2,1-3H3;1H/q+1;/p-1
|
|||
InChIKey |
FNPBHXSBDADRBT-UHFFFAOYSA-M
|
|||
CAS Number |
CAS 17773-10-3
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Acetylcholinesterase (AChE) | Target Info | Inhibitor | [1] |
KEGG Pathway | Glycerophospholipid metabolism | |||
Cholinergic synapse | ||||
Panther Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||
Muscarinic acetylcholine receptor 2 and 4 signaling pathway | ||||
Nicotinic acetylcholine receptor signaling pathway | ||||
Pathwhiz Pathway | Phospholipid Biosynthesis | |||
Pathway Interaction Database | ATF-2 transcription factor network | |||
WikiPathways | Monoamine Transport | |||
Biogenic Amine Synthesis | ||||
Acetylcholine Synthesis | ||||
Integrated Pancreatic Cancer Pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | Structure-based alignment and comparative molecular field analysis of acetylcholinesterase inhibitors. J Med Chem. 1996 Dec 20;39(26):5064-71. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.